Jiankai Liang

1.1k total citations
25 papers, 386 citations indexed

About

Jiankai Liang is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Jiankai Liang has authored 25 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 14 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Jiankai Liang's work include Virus-based gene therapy research (22 papers), CAR-T cell therapy research (11 papers) and Animal Virus Infections Studies (6 papers). Jiankai Liang is often cited by papers focused on Virus-based gene therapy research (22 papers), CAR-T cell therapy research (11 papers) and Animal Virus Infections Studies (6 papers). Jiankai Liang collaborates with scholars based in China and United States. Jiankai Liang's co-authors include Guangmei Yan, Yuan Lin, Jing Cai, Wenbo Zhu, Jun Hu, Haipeng Zhang, Yaqian Tan, Xingwen Su, Xincheng Liu and Kai Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Jiankai Liang

22 papers receiving 357 citations

Peers

Countries citing papers authored by Jiankai Liang

Since Specialization

Citations

This map shows the geographic impact of Jiankai Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiankai Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiankai Liang more than expected).

Fields of papers citing papers by Jiankai Liang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiankai Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiankai Liang. The network helps show where Jiankai Liang may publish in the future.

Co-authorship network of co-authors of Jiankai Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiankai Liang. A scholar is included among the top collaborators of Jiankai Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiankai Liang. Jiankai Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reduced oxytocin signaling in the dBNST drives the transition from acute pain to persistent anxiety 2025 ·Current Biology ·(unknown), Yuxin Qin, Lian Huang, (unknown), (unknown), Xiaodan Yu, (unknown), Jiankai Liang, Weiwei Xiao, (unknown), (unknown), Boxing Li, Lianyan Huang	0
2	Enhancing antitumor efficacy of oncolytic virus M1 via albendazole-sustained CD8+ T cell activation 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), Bo Zhu, (unknown), (unknown), (unknown), (unknown), (unknown), Yuan Lin, (unknown), Guangmei Yan, Jiankai Liang, Jun Hu	4
3	Arming oncolytic M1 virus with gasdermin E enhances antitumor efficacy in breast cancer 2024 ·iScience ·Xiaoyu Chen, Ying Liu, Wenbo Zhu, (unknown), Wei Song, Jing Cai, Lin Yuan, Jiankai Liang, Guangmei Yan, Li Guo, (unknown)	4
4	Pharmacokinetic enhancement of oncolytic virus M1 by inhibiting JAK‒STAT pathway 2024 ·Acta Pharmaceutica Sinica B ·Jingyi Tan, Jiayu Zhang, Cheng Hu, Gongwei Wang, (unknown), Chaoqun Wang, Dan Jia, (unknown), Jun Hu, Wenbo Zhu, Jiankai Liang, Jing Cai, Ying Liu, Guangmei Yan, Yuan Lin	6
5	STT3A-mediated viral N-glycosylation underlies the tumor selectivity of oncolytic virus M1 2023 ·Oncogene ·(unknown), Xudong Jia, Yuanzhu Gao, (unknown), Dan Jia, (unknown), Jing Cai, Jiankai Liang, Wenbo Zhu, Jun Hu, Guangmei Yan, Qinfen Zhang, Yuan Lin	0
6	Directed natural evolution generates a next-generation oncolytic virus with a high potency and safety profile 2023 ·Nature Communications ·Li Guo, (unknown), Yang Liu, Xiaoyu Chen, (unknown), (unknown), (unknown), Xudong Jia, Qinfen Zhang, Yuanzhu Gao, Zhezhi Deng, Tao Zuo, Jun Hu, Wenbo Zhu, Jing Cai, Guangmei Yan, Jiankai Liang, Yuan Lin	12
7	Oncolytic virus M1 functions as a bifunctional checkpoint inhibitor to enhance the antitumor activity of DC vaccine 2023 ·Cell Reports Medicine ·Dan Jia, Jing Cai, (unknown), Chaoqun Wang, Shanyu Huang, Ying Zeng, (unknown), (unknown), (unknown), Jiayu Zhang, Jun Hu, Ying Liu, Xingwen Su, Wenbo Zhu, Guangmei Yan, Jiankai Liang, Yuan Lin	15
8	Overcoming resistance to oncolytic virus M1 by targeting PI3K-γ in tumor-associated myeloid cells 2022 ·Molecular Therapy ·Yang Liu, (unknown), Xiaoting Xiao, Yinting Chen, (unknown), Wenfeng Liu, Yaqian Tan, Wenbo Zhu, Jun Hu, Jiankai Liang, Guangmei Yan, Yuan Lin, Jing Cai	5
9	Real-Time Visualization and Quantification of Oncolytic M1 Virus In Vitro and In Vivo 2021 ·Human Gene Therapy ·Wenbo Zhu, Jiankai Liang, Jingyi Tan, Li Guo, Jing Cai, Jun Hu, Guangmei Yan, Yang Liu, Jiayu Zhang, (unknown), Dan Jia, (unknown), Xingwen Su, Pengxin Qiu, Yuan Lin	12
10	Necroptotic virotherapy of oncolytic alphavirus M1 cooperated with Doxorubicin displays promising therapeutic efficacy in TNBC 2021 ·Oncogene ·Jiayu Zhang, Ying Liu, Jingyi Tan, Yanming Zhang, (unknown), Ziqing Lin, Xincheng Liu, (unknown), Xiaozhi Yang, (unknown), (unknown), Dan Jia, Yuwei Zhou, Jing Cai, Yuan Lin, Jiankai Liang, Jun Hu, Guangmei Yan, Wenbo Zhu	35
11	Visualization of the Oncolytic Alphavirus M1 Life Cycle in Cancer Cells 2021 ·Virologica Sinica ·Dan Jia, Lin Nie, Xudong Jia, (unknown), Jing Cai, Yuan Lin, Jun Hu, Wenbo Zhu, Yinyin Li, Dong Chen, Ying Liu, (unknown), Guangmei Yan, Jiankai Liang, Qinfen Zhang	4
12	Systematic Characterization of the Biodistribution of the Oncolytic Virus M1 2020 ·Human Gene Therapy ·Jing Cai, Wenbo Zhu, Yuan Lin, Suzhen Zhang, Xueqing Chen, Shoufang Gong, (unknown), Jun Hu, Guangmei Yan, Jiankai Liang	18
13	Lonidamine potentiates the oncolytic efficiency of M1 virus independent of hexokinase 2 but via inhibition of antiviral immunity 2020 ·Cancer Cell International ·Jing Cai, Wenbo Zhu, Yuan Lin, Jun Hu, Xincheng Liu, (unknown), Ying Liu, Cheng Hu, (unknown), Shoufang Gong, Guangmei Yan, Jiankai Liang	7
14	Suppression of CCDC6 sensitizes tumor to oncolytic virus M1 2020 ·Neoplasia ·Ying Liu, Ke Li, Wenbo Zhu, (unknown), Wentao Huang, Xincheng Liu, Yuan Lin, Jing Cai, Guangmei Yan, Jianguang Qiu, Liang Peng, Jiankai Liang, (unknown)	11
15	Intravenous injection of the oncolytic virus M1 awakens antitumor T cells and overcomes resistance to checkpoint blockade 2020 ·Cell Death and Disease ·Yang Liu, Jing Cai, Wenfeng Liu, Yuan Lin, Li Guo, Xincheng Liu, Zhen Qin, (unknown), Yanming Zhang, Xingwen Su, Kai Deng, Guangmei Yan, Jiankai Liang	45
16	Intravenous injections of the oncolytic virus M1 as a novel therapy for muscle-invasive bladder cancer 2018 ·Cell Death and Disease ·(unknown), Ying Liu, Yuan Lin, Jiankai Liang, Wenwen Zhong, Ke Li, Wentao Huang, Dejuan Wang, Guangmei Yan, Wenbo Zhu, Jianguang Qiu, Xin Gao	28
17	Association of Low Zinc Finger Antiviral Protein Expression with Progression and Poor Survival of Patients with Hepatocellular Carcinoma 2018 ·Cellular Physiology and Biochemistry ·Ying Liu, (unknown), Wenbo Zhu, Wenxiong Xu, (unknown), Yuan Lin, Jing Cai, Jiankai Liang, Xiang Zhu, Zhiliang Gao, Guangmei Yan, Liang Peng	6
18	Inhibition of the mevalonate pathway enhances cancer cell oncolysis mediated by M1 virus 2018 ·Nature Communications ·Jiankai Liang, Li Guo, Kai Li, Xiao Xiao, Wenbo Zhu, Xiaoke Zheng, Jun Hu, Haipeng Zhang, Jing Cai, Yaya Yu, Yaqian Tan, Chuntao Li, Xincheng Liu, (unknown), Ying Liu, Pengxin Qiu, Xingwen Su, (unknown), Yuan Lin, Guangmei Yan	24
19	Targeting VCP enhances anticancer activity of oncolytic virus M1 in hepatocellular carcinoma 2017 ·Science Translational Medicine ·Haipeng Zhang, Kai Li, Yuan Lin, Fan Xing, Xiao Xiao, Jing Cai, Wenbo Zhu, Jiankai Liang, Yaqian Tan, Liwu Fu, Fang Wang, Wei Yin, Bingzheng Lu, Pengxin Qiu, Xingwen Su, Shoufang Gong, Xuetao Bai, Jun Hu, Guangmei Yan	53
20	A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1 2016 ·Oncotarget ·Kai Li, Jiankai Liang, Yuan Lin, Haipeng Zhang, Xiao Xiao, Yaqian Tan, Jing Cai, Wenbo Zhu, Fan Xing, Jun Hu, Guangmei Yan	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact